Evidence map›Paper›PMID 37323810›Full record

ArticleACS sustainable chemistry & engineering2023

Realizing the Continuous Chemoenzymatic Synthesis of Anilines Using an Immobilized Nitroreductase.

Sebastian C Cosgrove, Gavin J Miller, Amin Bornadel, Beatriz Dominguez

Open access · hybridAbstract read
In one paragraph

Article in ACS sustainable chemistry & engineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Advances and Challenges in Bioprocess Optimization for the Synthesis of Sugar Nucleotides.Chembiochem : a European journal of chemical biology · 2025
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sebastian C CosgroveSchool of Chemical and Physical Sciences & Centre for Glycoscience, Keele University, Keele, Staffordshire ST5 5BG, United Kingdom.ORCID https://orcid.org/0000-0001-9541-7201
Gavin J MillerSchool of Chemical and Physical Sciences & Centre for Glycoscience, Keele University, Keele, Staffordshire ST5 5BG, United Kingdom.ORCID https://orcid.org/0000-0001-6533-3306
Amin BornadelJohnson Matthey, 28 Cambridge Science Park, Milton Rd, Cambridge CB4 0FP, United Kingdom.
Beatriz DominguezJohnson Matthey, 28 Cambridge Science Park, Milton Rd, Cambridge CB4 0FP, United Kingdom.
Johnson Matthey (United Kingdom) · GBKeele University · GB

Funding

Medical Research Council MR/T019522/1
6 · The paper itself

Abstract

The use of biocatalysis for classically synthetic transformations has seen an increase in recent years, driven by the sustainability credentials bio-based approaches can offer the chemical industry. Despite this, the biocatalytic reduction of aromatic nitro compounds using nitroreductase biocatalysts has not received significant attention in the context of synthetic chemistry. Herein, a nitroreductase (NR-55) is demonstrated to complete aromatic nitro reduction in a continuous packed-bed reactor for the first time. Immobilization on an amino-functionalized resin with a glucose dehydrogenase (GDH-101) permits extended reuse of the immobilized system, all operating at room temperature and pressure in aqueous buffer. By transferring into flow, a continuous extraction module is incorporated, allowing the reaction and workup to be continuously undertaken in a single operation. This is extended to showcase a closed-loop aqueous phase, permitting reuse of the contained cofactors, with a productivity of >10 g

Identifiers

PMID37323810
PMCPMC10265703
OpenAlexW4379231983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.